Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MRD in AML: time for redefinition of CR?

Blood - 21 Mar 2013

Ossenkoppele Gert, Schuurhuis Gerrit Jan

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Core Binding Factors
Share to Genes, Neoplasm
Share to Leukemia, Myeloid, Acute
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23520326
DOI: 10.1182/blood-2013-01-480590

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MRD in AML: time for redefinition of CR?PMID 23520326Read ↗

Haematological cancer: MRD assessment - guiding decisions for patients with AML.Semantic proximity Read ↗

Monitoring minimal residual disease in AML.Semantic proximity Read ↗

PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.Semantic proximity Read ↗

Should minimal residual disease guide therapy in AML?Semantic proximity Read ↗

Minimal residual disease (MRD) monitoring and mutational landscape in AML with RUNX1-RUNX1T1: a study on 134 patients.Semantic proximity Read ↗

Acute myeloid leukemia: 2014 update on risk-stratification and management.Semantic proximity Read ↗

Targeting IDH: the next big thing in AML.Semantic proximity Read ↗

Molecular characteristics therapy in AML.Semantic proximity Read ↗

Minimal residual disease in acute myeloid leukemia: coming of age.Semantic proximity Read ↗

Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CRSemantic proximity Read ↗

First new drug approval for AML in 15 years.Semantic proximity Read ↗

Real-World Outcomes in NPM1-Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.